Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2437 to 2438 of 2438 entries
Sorted by: Best Match Show Resources per page
COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes.

Modern rheumatology case reports

Kawasaki T, Ooka S, Mizushima M, Nakamura Y, Ikeda H, Sakurada T, Suzuki S, Yamazaki K, Goto Y, Sakurai K, Yukitaka Y, Kiyokawa T, Tonooka K, Kunishima H, Kawahata K.
PMID: 34592766
Mod Rheumatol Case Rep. 2022 Jan 07;6(1):101-105. doi: 10.1093/mrcr/rxab032.

The coronavirus disease (COVID-19) is known to cause hyperferritinemia and haemophagocytic lymphohistiocytosis. Including this laboratory parameter, symptoms similar to COVID-19 have been observed in adult-onset Still's disease (AOSD), catastrophic antiphospholipid syndrome, macrophage activation syndrome, and septic shock, which has...

Cite
Kawasaki T, Ooka S, Mizushima M, et al. COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes. Mod Rheumatol Case Rep. 2022;6(1):101-105doi: 10.1093/mrcr/rxab032.
Kawasaki, T., Ooka, S., Mizushima, M., Nakamura, Y., Ikeda, H., Sakurada, T., Suzuki, S., Yamazaki, K., Goto, Y., Sakurai, K., Yukitaka, Y., Kiyokawa, T., Tonooka, K., Kunishima, H., & Kawahata, K. (2022). COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes. Modern rheumatology case reports, 6(1), 101-105. https://doi.org/10.1093/mrcr/rxab032
Kawasaki, Tatsuya, et al. "COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes." Modern rheumatology case reports vol. 6,1 (2022): 101-105. doi: https://doi.org/10.1093/mrcr/rxab032
Kawasaki T, Ooka S, Mizushima M, Nakamura Y, Ikeda H, Sakurada T, Suzuki S, Yamazaki K, Goto Y, Sakurai K, Yukitaka Y, Kiyokawa T, Tonooka K, Kunishima H, Kawahata K. COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes. Mod Rheumatol Case Rep. 2022 Jan 07;6(1):101-105. doi: 10.1093/mrcr/rxab032. PMID: 34592766; PMCID: PMC8500156.
Copy Download .nbib Format: NLM
Integrative cancer genomics in the era of precision cancer medicine.

Journal of human genetics

Inazawa J, Miki Y, Nakamura Y.
PMID: 34429508
J Hum Genet. 2021 Sep;66(9):843. doi: 10.1038/s10038-021-00970-6. Epub 2021 Aug 16.

No abstract available.

Cite
Inazawa J, Miki Y, Nakamura Y. Integrative cancer genomics in the era of precision cancer medicine. J Hum Genet. 2021;66(9):843doi: 10.1038/s10038-021-00970-6.
Inazawa, J., Miki, Y., & Nakamura, Y. (2021). Integrative cancer genomics in the era of precision cancer medicine. Journal of human genetics, 66(9), 843. https://doi.org/10.1038/s10038-021-00970-6
Inazawa, Johji, et al. "Integrative cancer genomics in the era of precision cancer medicine." Journal of human genetics vol. 66,9 (2021): 843. doi: https://doi.org/10.1038/s10038-021-00970-6
Inazawa J, Miki Y, Nakamura Y. Integrative cancer genomics in the era of precision cancer medicine. J Hum Genet. 2021 Sep;66(9):843. doi: 10.1038/s10038-021-00970-6. Epub 2021 Aug 16. PMID: 34429508.
Copy Download .nbib Format: NLM
Showing 2437 to 2438 of 2438 entries